Science Explorer Interactive view Map
Government institution · Tokyo · Japan

Pharmaceuticals and Medical Devices Agency

In research, Pharmaceuticals and Medical Devices Agency stands highest in Medicine (#7,986 of 17,978 worldwide), Health Sciences (#9,408 of 20,462 worldwide) and Life Sciences (#10,532 of 14,347 worldwide), over all time.

pmda.go.jp/english/index.htmlROR OpenAlex
World rank, 2022–2025
#19,670
of 28,054 · #21,073 all time
Rank in Japan
#561
of 1,070
Research works
461
▲ 29% vs 2013–17
Citations
5.4k
11.7 per fractional work
Top-10% rate
15.9%
record average 16.5%
Open access
53%
world 28%

What is Pharmaceuticals and Medical Devices Agency known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #7,986 of 17,978 14.8%188
Health SciencesDomain #9,408 of 20,462 14.4%202
Life SciencesDomain #10,532 of 14,347 12.1%132

Each strip is that field’s whole ranked pool, with the notch where Pharmaceuticals and Medical Devices Agency sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.49× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.82× its world share, 11 worksBiochemistry, Geneti…Immunology and Microbiology: 4.99× its world share, 6 worksImmunology and Micro…Neuroscience: 0.81× its world share, 2 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 28.37× its world share, 11 worksPharmacology, Toxico…Chemistry: 0.47× its world share, 1 worksChemistryComputer Science: 0.19× its world share, 2 worksComputer ScienceEngineering: 0.19× its world share, 3 worksEngineeringEnvironmental Science: 0.21× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.10× its world share, 0 worksMaterials ScienceMathematics: 3.14× its world share, 4 worksMathematicsPhysics and Astronomy: 0.18× its world share, 0 worksPhysics and AstronomyDentistry: 0.75× its world share, 0 worksDentistryHealth Professions: 0.86× its world share, 2 worksHealth ProfessionsMedicine: 2.24× its world share, 48 worksMedicineNursing: 0.31× its world share, 0 worksNursingVeterinary: 5.21× its world share, 1 worksVeterinaryBusiness, Management and Accounting: 0.44× its world share, 2 worksBusiness, Management…Decision Sciences: 1.39× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 4.00× its world share, 9 worksEconomics, Econometr…Psychology: 0.36× its world share, 1 worksPsychologySocial Sciences: 0.16× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 28.4×. Every wedge is a field page.

Who are the top researchers at Pharmaceuticals and Medical Devices Agency?

Ranked on the composite score, Yoshiaki Uyama, Chieko Ishiguro and Nobuhiro Handa lead among researchers whose main affiliation is Pharmaceuticals and Medical Devices Agency.

  1. 1 Yoshiaki Uyama Japan · #409,826 worldwide 56 citations · 28 works
  2. 2 Chieko Ishiguro Japan · #722,196 worldwide 21 citations · 15 works
  3. 3 Nobuhiro Handa Japan · #1,115,048 worldwide 15 citations · 15 works
  4. 4 Junko Sato Japan · #1,369,697 worldwide 11 citations · 26 works
All ranked researchers at Pharmaceuticals and Medical Devices Agency

Which keywords describe research at Pharmaceuticals and Medical Devices Agency?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Adverse Drug Reactions, Clinical Trials, Pharmaceutical Industry, Drug Development Costs, Generic Drugs, Healthcare Communication, Clinical Pharmacy and Pharmaceutical Care.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Adverse Drug Reactions11▲ 187×3 topics
  2. Clinical Trials7▲ 9.9×9 topics
  3. Pharmaceutical Industry7▲ 166×2 topics
  4. Drug Development Costs6▲ 225×1 topic
  5. Generic Drugs6▲ 225×1 topic
  6. Epidemiology6▲ 1.30×33 topics
  7. Clinical Pharmacy6▲ 456×1 topic
  8. Healthcare Communication6▲ 58×2 topics
  9. Pharmaceutical Care6▲ 456×1 topic
  10. Biomarkers5▲ 6.1×7 topics
  11. Monoclonal Antibodies5▲ 47×3 topics
  12. Biopharmaceuticals4▲ 76×2 topics
  13. Data Mining4▲ 5.2×2 topics
  14. Immunogenicity4▲ 91×3 topics
  15. Global Governance4▲ 17×3 topics
  16. Oxidative Stress4▲ 2.3×14 topics
  17. Drug Development4▲ 41×3 topics
  18. Clinical Outcomes4▲ 16×2 topics
  19. Bioanalytical Methods4▲ 163×1 topic
  20. Biosimilars4▲ 163×1 topic
  21. Regulatory Challenges4▲ 37×2 topics
  22. Adaptive Designs4▲ 156×1 topic
  23. False Discovery Rate4▲ 156×1 topic
  24. Regenerative Medicine4▲ 12×2 topics
  25. Patient Safety3▲ 21×3 topics
  26. Ethical Issues3▲ 28×2 topics
  27. Pharmacovigilance3▲ 196×1 topic
  28. Signal Detection3▲ 196×1 topic
  29. Direct-to-Consumer Marketing3▲ 125×1 topic
  30. Stem Cell Regulation3▲ 125×1 topic
  31. Lymphoma3▲ 15×2 topics
  32. Tumor Regression3▲ 22×2 topics
  33. SARS-CoV-22▲ 6.8×5 topics
  34. Cost-effectiveness Analysis2▲ 26×1 topic
  35. Health Utility Measures2▲ 26×1 topic
  36. Pharmacokinetics2▲ 8.4×4 topics
  37. ACE2 Receptor2▲ 8.7×2 topics
  38. CAR T Cells2▲ 28×1 topic
  39. Chimeric Antigen Receptor2▲ 28×1 topic
  40. Medication Adherence2▲ 38×2 topics

Which research topics does Pharmaceuticals and Medical Devices Agency publish most on?

By volume in 2022–2025: Pharmaceutical Economics and Policy, Pharmacy and Medical Practices, Biosimilars and Bioanalytical Methods and Statistical Methods in Clinical Trials.

Pharmaceutical Economics and Policy: 6 fractional worksPharmacy and Medical Practices: 6 fractional worksBiosimilars and Bioanaly…4Biosimilars and Bioanalytical Methods: 4 fractional worksStatistical Methods in C…4Statistical Methods in Clinical Trials: 4 fractional worksPharmacovigilance and Adverse Drug Reactions: 3 fractional worksBiomedical Ethics and Regulation: 3 fractional worksHealth Systems, Economic…2Health Systems, Economic Evaluations, Quality of Life: 2 fractional worksCAR-T cell therapy research: 2 fractional worksPharmaceutical studies and practices: 2 fractional worksScience, Research, and Medicine: 2 fractional works
Economics and EconometricsPharmacologyImmunologyStatistics and Probability5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Pharmaceutical Economics and Policy Economics and Econometrics 6 works
  2. 2 Pharmacy and Medical Practices Pharmacology 6 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 4 works
  4. 4 Statistical Methods in Clinical Trials Statistics and Probability 4 works
  5. 5 Pharmacovigilance and Adverse Drug Reactions Toxicology 3 works
  6. 6 Biomedical Ethics and Regulation Physiology 3 works
  7. 7 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 2 works
  8. 8 CAR-T cell therapy research Oncology 2 works
  9. 9 Pharmaceutical studies and practices Pediatrics, Perinatology and Child Health 2 works
  10. 10 Science, Research, and Medicine Reproductive Medicine 2 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available53.3%not open46.7%

World: 28% of research is openly available.

with international co-authors20.4%domestic only79.6%

World: 19% is written across borders.

How has Pharmaceuticals and Medical Devices Agency's research output changed?

Output in 2018–2022 was 29% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.